Ethyl pyruvate protects PC12 cells from dopamine-induced apoptosis

被引:45
作者
Wang, LZ [1 ]
Sun, WC [1 ]
Zhu, XZ [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Dept Pharmacol 2, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; dopamine; ethyl pyruvate; oxidative stress; nuclear transcription factor kappa B; p53;
D O I
10.1016/j.ejphar.2004.12.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pyruvate acid can protect cells against oxidative damage. However, its instability limits its usefulness as a therapeutic agent. In this study, we examined the effect of ethyl pyruvate, an aliphatic ester derived from pyruvate acid, on dopamine-induced cytotoxicity in rat pheochromocytoma PC12 cells. The results demonstrated that dopamine induced apoptosis in PC12 cells accompanied with increases of intercellular reactive oxygen species, nuclear translocation of nuclear transcription factor kappa B (NF-kappaB) and expression of p53 and decrease of mitochondrial transmembrane potential. Ethyl pyruvate markedly reduced the dopamine-induced production of reactive oxygen species, nuclear translocation of NF-kappaB, upregulation of p53, loss of mitochondrial transmembrane potential and apoptosis in PC12 cells. The results suggested that ethyl pyruvate might protect PC12 cells against dopamine by suppressing intercellular oxidative stress and modulating key signal pathways of apoptosis, and that ethyl pyruvate might be used as a potential therapeutic agent for Parkinson's disease. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 66 条
[1]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[2]  
Beal MF, 2003, ANN NY ACAD SCI, V991, P120
[3]   Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders [J].
Ben-Shachar, D ;
Zuk, R ;
Gazawi, H ;
Ljubuncic, P .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (10) :1965-1974
[4]   Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].
Berman, SB ;
Hastings, TG .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137
[5]   Activation of the nuclear factor-κB is a key event in brain tolerance [J].
Blondeau, N ;
Widmann, C ;
Lazdunski, M ;
Heurteaux, C .
JOURNAL OF NEUROSCIENCE, 2001, 21 (13) :4668-4677
[6]   6-hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells [J].
Blum, D ;
Torch, S ;
Nissou, MF ;
Verna, JM .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (04) :473-481
[7]   Pathophysiology of Parkinson's disease [J].
Bonnet, AM ;
Houeto, JL .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :117-121
[8]   Inhibition of nuclear factor κB by direct modification in whole cells -: Mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers [J].
Brennan, P ;
O'Neill, LAJ .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (07) :965-973
[9]   Activation of nuclear factor κB and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IκBα [J].
Bui, NT ;
Livolsi, A ;
Peyron, JF ;
Prehn, JHM .
JOURNAL OF CELL BIOLOGY, 2001, 152 (04) :753-763
[10]   PYRUVATE-ENHANCED PHOSPHORYLATION POTENTIAL AND INOTROPISM IN NORMOXIC AND POSTISCHEMIC ISOLATED WORKING HEART - NEAR-COMPLETE PREVENTION OF REPERFUSION CONTRACTILE FAILURE [J].
BUNGER, R ;
MALLET, RT ;
HARTMAN, DA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 180 (01) :221-233